leisure time -WSS

leisure time

author：entertainment 2025-09-30 00:37:06 - browse：281

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Kristina Burow of ARCH Venture Partners shares her next big bets STAT

knowledge

WSS

In key trial, Verve's treatment lowers cholesterol levels in patients

Congress must reauthorize a committee to support older Americans

NYU radiologists take on the challenge of expensive MRI machines

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

U.K. considers world's first use of meningitis vaccine to address gonorrhea

A Q&A with Aletha Maybank, AMA’s chief health equity officer

focus

leisure time

Sign up for Morning Rounds

Wikipedia

Peter Hotez and the public health issue of online harassment

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Sports medicine is finally prioritizing gender equality

Why getting cancer drugs just got harder for rural patients

The cancer drug shortage isn’t new — and neither are the solutions

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

23andMe had bad news about my health. I wish a person had delivered it

FDA's Woodcock to retire early next year

Heart attack and stroke risk calculators need revising

Biotech companies concerned about China biosecurity crackdown

explore

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

In search for therapies for solid tumors, companies turn to claudin

How to address the problem of discarded donor organs

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

An inside look at PIPEs, biotech's buzzy new financing tool

Wegovy, Zepbound and weight loss drugs that preserve muscle

focus

knowledge

entertainment

hotspot